Skip to main content
Erschienen in: Obesity Surgery 3/2020

30.11.2019 | Original Contributions

The Effect of Bariatric Surgery on Migraines: a Systematic Review and Meta-analysis

verfasst von: Jerry T. Dang, Jeremy K. H. Lee, Janice Y. Kung, Noah J. Switzer, Shahzeer Karmali, Daniel W. Birch

Erschienen in: Obesity Surgery | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Recent research has demonstrated an association between obesity and migraine headaches. Furthermore, studies have demonstrated that migraine improvement can occur with significant weight loss. Given that bariatric surgery is the most effective intervention for obesity and obesity-related comorbidities, there is potential for bariatric surgery to improve migraine symptoms. The objective of this study was to conduct a systematic review and meta-analysis to determine the effect of bariatric surgery on migraine headaches.

Methods

A comprehensive literature search from database inception to December 2018 was conducted for studies examining the effect of bariatric surgery on migraines. Patients of all ages who had a history of migraines undergoing primary bariatric surgery were included. Primary outcomes included migraine frequency, severity, and disability.

Results

Four studies were included (n = 159). Frequency of migraines was markedly reduced after bariatric surgery, with fewer symptomatic days suffered by patients per month post-operatively (mean difference [MD] - 5.56 days, 95%CI 0.14 to 10.99, p = 0.04). The degree of migraine headache-related disability as measured by the Migraine Disability Assessment Scale (MIDAS) was also significantly lower following bariatric surgery (MD - 14.72, 95%CI 10.08 to 19.36, p < 0.001). The severity of migraine headache pain before and after surgery was reduced with borderline statistical significance (MD - 3.53, 95%CI - 0.12 to 7.17, p = 0.06).

Conclusion

Migraine severity, frequency, and headache-related disability were improved 6 months after bariatric surgery. However, this systematic review was limited by a low number of studies and larger high-quality, randomized trials are needed to determine the effect of bariatric surgery on migraine headaches.
Literatur
1.
Zurück zum Zitat Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. New Zealand. 2015;33:673–89.CrossRef Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. New Zealand. 2015;33:673–89.CrossRef
2.
Zurück zum Zitat Rogula T, Thodiyil PA, Brethauer SA, et al. In: Schauer PR, Schirmer BD, Brethauer SA, editors. Laparoscopic Roux-en-Y gastric bypass: outcomes BT - minimally invasive bariatric surgery. New York: Springer New York; 2007. p. 271–80. Rogula T, Thodiyil PA, Brethauer SA, et al. In: Schauer PR, Schirmer BD, Brethauer SA, editors. Laparoscopic Roux-en-Y gastric bypass: outcomes BT - minimally invasive bariatric surgery. New York: Springer New York; 2007. p. 271–80.
3.
Zurück zum Zitat Bigal ME, Rapoport AM. Obesity and chronic daily headache. Curr Pain Headache Rep. United States. 2012;16:101–9.CrossRef Bigal ME, Rapoport AM. Obesity and chronic daily headache. Curr Pain Headache Rep. United States. 2012;16:101–9.CrossRef
4.
Zurück zum Zitat Jahromi SR, Abolhasani M, Meysamie A, et al. The effect of body fat mass and fat free mass on migraine headache. Iran J Neurol. Iran. 2013;12:23–7. Jahromi SR, Abolhasani M, Meysamie A, et al. The effect of body fat mass and fat free mass on migraine headache. Iran J Neurol. Iran. 2013;12:23–7.
5.
Zurück zum Zitat Horev A, Wirguin I, Lantsberg L, et al. A high incidence of migraine with aura among morbidly obese women. Headache. United States. 2005;45:936–8. Horev A, Wirguin I, Lantsberg L, et al. A high incidence of migraine with aura among morbidly obese women. Headache. United States. 2005;45:936–8.
6.
Zurück zum Zitat Peres MFP, Lerario DDG, Garrido AB, et al. Primary headaches in obese patients. Arq Neuropsiquiatr. Brazil. 2005;63:931–3. Peres MFP, Lerario DDG, Garrido AB, et al. Primary headaches in obese patients. Arq Neuropsiquiatr. Brazil. 2005;63:931–3.
7.
Zurück zum Zitat Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. United States. 2001;41:646–57. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. United States. 2001;41:646–57.
8.
Zurück zum Zitat Peterlin BL, Rosso AL, Rapoport AM, et al. Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache. United States. 2010;50:52–62. Peterlin BL, Rosso AL, Rapoport AM, et al. Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache. United States. 2010;50:52–62.
9.
Zurück zum Zitat Robberstad L, Dyb G, Hagen K, et al. An unfavorable lifestyle and recurrent headaches among adolescents: the HUNT study. Neurology. United States. 2010;75:712–7. Robberstad L, Dyb G, Hagen K, et al. An unfavorable lifestyle and recurrent headaches among adolescents: the HUNT study. Neurology. United States. 2010;75:712–7.
10.
Zurück zum Zitat Ford ES, Li C, Pearson WS, et al. Body mass index and headaches: findings from a national sample of US adults. Cephalalgia. England. 2008;28:1270–6. Ford ES, Li C, Pearson WS, et al. Body mass index and headaches: findings from a national sample of US adults. Cephalalgia. England. 2008;28:1270–6.
11.
Zurück zum Zitat Scher AI, Stewart WF, Ricci JA, et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. United States. 2003;106:81–9. Scher AI, Stewart WF, Ricci JA, et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. United States. 2003;106:81–9.
12.
Zurück zum Zitat Bond DS, Roth J, Nash JM, et al. Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev. England. 2011;12:e362–71. Bond DS, Roth J, Nash JM, et al. Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev. England. 2011;12:e362–71.
13.
Zurück zum Zitat Verrotti A, Agostinelli S, D’Egidio C, et al. Impact of a weight loss program on migraine in obese adolescents. Eur J Neurol. England. 2013;20:394–7. Verrotti A, Agostinelli S, D’Egidio C, et al. Impact of a weight loss program on migraine in obese adolescents. Eur J Neurol. England. 2013;20:394–7.
14.
Zurück zum Zitat Peterlin BL. Bariatric surgery in obese migraineurs: mounting evidence but important questions remain. Cephalalgia. England. 2011;31:1333–5. Peterlin BL. Bariatric surgery in obese migraineurs: mounting evidence but important questions remain. Cephalalgia. England. 2011;31:1333–5.
15.
Zurück zum Zitat Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, et al. IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures. Obes Surg. 2018;28:3783–94. Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, et al. IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures. Obes Surg. 2018;28:3783–94.
16.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
17.
Zurück zum Zitat Bond DS, Vithiananthan S, Nash JM, et al. Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology. United States. 2011;76:1135–8. Bond DS, Vithiananthan S, Nash JM, et al. Improvement of migraine headaches in severely obese patients after bariatric surgery. Neurology. United States. 2011;76:1135–8.
18.
Zurück zum Zitat Novack V, Fuchs L, Lantsberg L, et al. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. England. 2011;31:1336–42. Novack V, Fuchs L, Lantsberg L, et al. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. England. 2011;31:1336–42.
19.
Zurück zum Zitat Razeghi Jahromi S, Abolhasani M, Ghorbani Z, et al. Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache. Obes Surg. United States. 2018;28:87–96. Razeghi Jahromi S, Abolhasani M, Ghorbani Z, et al. Bariatric surgery promising in migraine control: a controlled trial on weight loss and its effect on migraine headache. Obes Surg. United States. 2018;28:87–96.
20.
Zurück zum Zitat Gunay Y, Jamal M, Capper A, et al. Roux-en-Y gastric bypass achieves substantial resolution of migraine headache in the severely obese: 9-year experience in 81 patients. Surg Obes Relat Dis. United States. 2013;9:55–62. Gunay Y, Jamal M, Capper A, et al. Roux-en-Y gastric bypass achieves substantial resolution of migraine headache in the severely obese: 9-year experience in 81 patients. Surg Obes Relat Dis. United States. 2013;9:55–62.
21.
Zurück zum Zitat Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73:712–6. Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73:712–6.
22.
Zurück zum Zitat Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Collab. 2011;4. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Collab. 2011;4.
23.
Zurück zum Zitat Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
24.
Zurück zum Zitat Peterlin BL, Bigal ME, Tepper SJ, et al. Migraine and adiponectin: is there a connection? Cephalalgia England. 2007;27:435–46. Peterlin BL, Bigal ME, Tepper SJ, et al. Migraine and adiponectin: is there a connection? Cephalalgia England. 2007;27:435–46.
25.
Zurück zum Zitat Bigal ME, Lipton RB, Holland PR, et al. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology. United States. 2007;68:1851–61. Bigal ME, Lipton RB, Holland PR, et al. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology. United States. 2007;68:1851–61.
26.
Zurück zum Zitat Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. Medknow Publications & Media Pvt Ltd. 2012;15:S15–22.CrossRef Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. Medknow Publications & Media Pvt Ltd. 2012;15:S15–22.CrossRef
28.
Zurück zum Zitat Tepper DE. Migraine and Obesity. Headache J Head Face Pain. John Wiley & Sons, Ltd (10.1111). 2013;53:719–20.CrossRef Tepper DE. Migraine and Obesity. Headache J Head Face Pain. John Wiley & Sons, Ltd (10.1111). 2013;53:719–20.CrossRef
29.
Zurück zum Zitat Gruber H-J, Bernecker C, Pailer S, et al. Lipid profile in normal weight migraineurs - evidence for cardiovascular risk. Eur J Neurol. 2010;17:419–25. Gruber H-J, Bernecker C, Pailer S, et al. Lipid profile in normal weight migraineurs - evidence for cardiovascular risk. Eur J Neurol. 2010;17:419–25.
30.
Zurück zum Zitat Kuo LE, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med. United States. 2007;13:803–11. Kuo LE, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med. United States. 2007;13:803–11.
31.
Zurück zum Zitat Gallai V, Sarchielli P, Trequattrini A, et al. Neuropeptide Y in juvenile migraine and tension-type headache. Headache. United States. 1994;34:35–40. Gallai V, Sarchielli P, Trequattrini A, et al. Neuropeptide Y in juvenile migraine and tension-type headache. Headache. United States. 1994;34:35–40.
32.
Zurück zum Zitat Baranowska B, Wolinska-Witort E, Martynska L, et al. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women. Neuro Endocrinol Lett. Sweden. 2005;26:293–6. Baranowska B, Wolinska-Witort E, Martynska L, et al. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women. Neuro Endocrinol Lett. Sweden. 2005;26:293–6.
33.
Zurück zum Zitat Lambert GW, Straznicky NE, Lambert EA, et al. Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. Pharmacol Ther. England. 2010;126:159–72. Lambert GW, Straznicky NE, Lambert EA, et al. Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. Pharmacol Ther. England. 2010;126:159–72.
34.
Zurück zum Zitat Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. United States. 2004;44:53–64.CrossRef Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. United States. 2004;44:53–64.CrossRef
35.
Zurück zum Zitat Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. United States. 2004;240:236–42. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. United States. 2004;240:236–42.
36.
Zurück zum Zitat Verrotti A, Carotenuto M, Altieri L, et al. Migraine and obesity: Metabolic parameters and response to a weight loss programme. Pediatr Obes. 2015;10:220–5. Verrotti A, Carotenuto M, Altieri L, et al. Migraine and obesity: Metabolic parameters and response to a weight loss programme. Pediatr Obes. 2015;10:220–5.
37.
Zurück zum Zitat Peterlin BL. The role of the adipocytokines adiponectin and leptin in migraine. J Am Osteopath Assoc. United States. 2009;109:314–7.PubMed Peterlin BL. The role of the adipocytokines adiponectin and leptin in migraine. J Am Osteopath Assoc. United States. 2009;109:314–7.PubMed
38.
Zurück zum Zitat Maeda T, Kiguchi N, Kobayashi Y, et al. Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proc Natl Acad Sci U S A. 2009;106:13076–81. Maeda T, Kiguchi N, Kobayashi Y, et al. Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proc Natl Acad Sci U S A. 2009;106:13076–81.
39.
Zurück zum Zitat Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. United States. 2002;59:1492–5.CrossRef Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. United States. 2002;59:1492–5.CrossRef
40.
Zurück zum Zitat Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep. United States. 2008;8:87–93.CrossRef Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep. United States. 2008;8:87–93.CrossRef
41.
Zurück zum Zitat Banik R. Obesity and the role of nonsurgical and surgical weight reduction in idiopathic intracranial hypertension. Int Ophthalmol Clin. United States. 2014;54:27–41.CrossRef Banik R. Obesity and the role of nonsurgical and surgical weight reduction in idiopathic intracranial hypertension. Int Ophthalmol Clin. United States. 2014;54:27–41.CrossRef
42.
Zurück zum Zitat Manfield JH, Yu KK-H, Efthimiou E, et al. Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension? A systematic review and comparison of meta-analyses. Obes Surg. Springer US. 2017;27:513–21. Manfield JH, Yu KK-H, Efthimiou E, et al. Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension? A systematic review and comparison of meta-analyses. Obes Surg. Springer US. 2017;27:513–21.
Metadaten
Titel
The Effect of Bariatric Surgery on Migraines: a Systematic Review and Meta-analysis
verfasst von
Jerry T. Dang
Jeremy K. H. Lee
Janice Y. Kung
Noah J. Switzer
Shahzeer Karmali
Daniel W. Birch
Publikationsdatum
30.11.2019
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 3/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04290-9

Weitere Artikel der Ausgabe 3/2020

Obesity Surgery 3/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.